Compare BIO-TECHNE Corp (TECH) vs Walmart Stores Inc (WMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs Walmart Stores Inc — how do they compare? BIO-TECHNE Corp trades at $72.13 (market cap $11.24B), while Walmart Stores Inc trades at $113.19 (market cap $896.56B). The key difference: Walmart Stores Inc is far larger — about 79.8× BIO-TECHNE Corp's market cap, and Walmart Stores Inc pays the higher dividend (0.88%). Which is the better fit depends on your goals.
| TECH | WMT | |
|---|---|---|
Market Cap | $11.24B | $896.56B |
Sector | Health | Consumer Staples |
52-Week High | $72.29 | $134.20 |
52-Week Low | $43.31 | $96.05 |
Enterprise Value | $11.32B | $960.01B |
Dividend Yield | 0.44% | 0.88% |
Volume | — | 5,675,288 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
Walmart (WMT) trades at $111.85, down 0.2% with a bearish technical signal despite strong fundamentals. The company reported consistent earnings beats in recent quarters with Q1 2026 EPS of $0.66 beating expectations. Revenue grew to $681B in 2025 with improving profit margins. Analyst consensus remains strongly bullish with a $142 price target, though technical indicators show near-term pressure with support at $109.
Walmart presents a compelling long-term investment with strong revenue growth and operational efficiency improvements. Key opportunities include expanding e-commerce capabilities and drone delivery services. Risks include competitive pressure from Amazon, margin compression from inflation, and legal challenges. The stock's current pullback may offer entry opportunity given Wall Street's positive outlook.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About Walmart Stores Inc
Walmart Inc. operates discount stores, supercenters, and neighborhood markets. The Company offers merchandise such as apparel, house wares, small appliances, electronics, musical instruments, books, home improvement, shoes, jewelry, toddler, games, household essentials, pets, pharmaceutical products, party supplies, and automotive tools. Walmart serves customers worldwide.
Read more on WMT →
